Рет қаралды 1,005
Dr. Emma Guttman presented on “What’s New in Atopic Dermatitis in 2023” for the annual Masterclasses in Dermatology Conference at The Ritz-Carlton in Sarasota, Florida in February 2023. What’s in the pipeline for atopic dermatitis (AD) patients? Dr. Guttman discusses the efficacy and safety of separate AD clinical trials for Dupilumab, Tralokinumab, Lebrikizumab, and several other potential treatments. In her presentation, Dr. Guttman also reviews the development of less invasive biomarkers in AD, such as tape stripping.